Financial reports
ARS
2023 FY
Annual report to shareholders
1 Nov 24
10-Q
2024 Q2
Quarterly report
14 Aug 24
10-Q
2024 Q1
Quarterly report
20 May 24
NT 10-Q
Notice of late quarterly filing
15 May 24
10-K
2023 FY
Annual report
15 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
ARS
2022 FY
Annual report to shareholders
24 Oct 23
10-Q
2023 Q3
Quarterly report
19 Oct 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
Current reports
8-K
Entry into a Material Definitive Agreement
17 Jun 24
8-K
Changes in Registrant's Certifying Accountant
20 Feb 24
8-K
Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
14 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
15 Dec 23
8-K
Other Events
13 Apr 23
8-K
Other Events
13 Mar 23
8-K
Submission of Matters to a Vote of Security Holders
9 Dec 22
8-K
Entry into a Material Definitive Agreement
12 Jul 22
8-K
Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed
12 Jul 22
8-K
Other Events
11 Jul 22
Registration and prospectus
S-3
Shelf registration
7 Oct 24
D
$2.50 mm in equity, sold $2.50 mm, 1 investor
17 Jun 24
424B5
Prospectus supplement for primary offering
12 Jul 22
S-8
Registration of securities for employees
5 Jul 22
S-3/A
Shelf registration (amended)
1 Apr 22
S-3
Shelf registration
25 Mar 22
424B3
Prospectus supplement
8 Mar 21
424B4
Prospectus supplement with pricing info
18 Dec 20
S-1MEF
Registration of additional securities for an S-1
17 Dec 20
FWP
Free writing prospectus
16 Dec 20
Proxies
DEFA14A
Additional proxy soliciting materials
1 Nov 24
DEF 14A
Definitive proxy
1 Nov 24
DEFA14A
Additional proxy soliciting materials
25 Oct 23
DEF 14A
Definitive proxy
24 Oct 23
DEFA14A
Additional proxy soliciting materials
19 Oct 22
DEF 14A
Definitive proxy
19 Oct 22
DEFA14A
Additional proxy soliciting materials
20 Oct 21
DEF 14A
Definitive proxy
19 Oct 21
Other
EFFECT
Notice of effectiveness
18 Oct 24
EFFECT
Notice of effectiveness
7 Apr 22
CORRESP
Correspondence with SEC
4 Apr 22
UPLOAD
Letter from SEC
31 Mar 22
EFFECT
Notice of effectiveness
18 Dec 20
CORRESP
Correspondence with SEC
15 Dec 20
CORRESP
Correspondence with SEC
15 Dec 20
UPLOAD
Letter from SEC
11 Dec 20
EFFECT
Notice of effectiveness
25 Sep 20
CERT
Certification of approval for exchange listing
24 Sep 20